Zydus Lifesciences Share Price
₹1036.90
as on
Zydus Lifesciences Stock Performance
as on September 15, 2025 at 4:01 pm IST
Day's Low
Day's High
₹1,033.05₹1,047
0.37%
Downside
0.97%
Upside
52 Week's Low
52 Week's High
₹795₹1,135.123.33%
Downside
9.47%
Upside
Zydus Lifesciences share price movements today
- Previous Close
- ₹1,044.75
- Open
- ₹1,047.00
- Volume
- 3.92L
- Upper Circuit
- ₹1,149.20
- Lower Circuit
- ₹940.30
- Day's Low - High
- ₹1,033.05 - ₹1,047
- 52 Week Low - High
- ₹795 - ₹1,135.1
Zydus Lifesciences Historical Returns
- 1 Month Return
- + 5.9 %
- 3 Month Return
- + 7.22 %
- 1 Year Return
- -6.37 %
- 3 Year Return
- + 181.68 %
- 5 Year Return
- + 178.56 %
Zydus Lifesciences Fundamentals
as on September 15, 2025 at 4:01 pm IST
Market Cap
₹1,05,126.30 Cr
Return on Equity (ROE)
31.29
PE Ratio (TTM)
22.99
Return on capital employed (ROCE)
30.47
Industry PE ratio
42.64
Beta (LTM)
0.81
P/B Ratio
4.2
Dividend Yield
1.24
PEG Ratio
5.83
Quarterly Earnings Growth YOY
1.57
EPS (TTM)
45.87
Sector
Pharmaceuticals
Book Value
238.1
Technical Analysis
Bullish
View Technical Analysis
Zydus Lifesciences Stock Valuation
as on September 15, 2025 at 4:01 pm IST
Zydus Lifesciences in the last 5 years
Lowest (7.34x)
March 7, 2022
Today (22.99x)
September 12, 2025
Industry (42.64x)
September 12, 2025
Highest (34.62x)
March 26, 2024
Today’s Price to Earnings Ratio: 22.99x
Zydus Lifesciences Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Zydus Lifesciences with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| HOLD | 1,05,126.30 | 35.71% | 0.61 | 4,614 | 23,241 | |
| BUY | 11,669.30 | -8.27% | 0.52 | 413 | 2,013 | |
| BUY | 64,125.12 | 6.73% | 0.60 | 3,483 | 31,723 | |
| BUY | 65,832.50 | 16.67% | 0.00 | 1,414 | 6,445 | |
| BUY | 46,993.23 | 11.19% | 0.56 | 927 | 3,749 |
Analyst Recommendation on Zydus Lifesciences Stock
Based on 30 analysts
36.67%
Buy
40.00%
Hold
23.33%
Sell
Based on 30 analysts, 40% of analysts recommend a 'HOLD' rating for Zydus Lifesciences. Average target price of ₹1011.5
Source: S&P Global Market Intelligence
Zydus Lifesciences Share Price Target
Get share price movements and forecasts by analysts on Zydus Lifesciences.
What analysts predicted
-3.18%DOWNSIDE
Target Price
₹1011.5
Current Price
₹1036.9
Analyzed by
30 Analysts
High
₹1183
Target
₹1011.50
Low
₹850
Zydus Lifesciences target price ₹1011.5, a slight downside of -3.18% compared to current price of ₹1036.9. According to 30 analysts rating.
Source: S&P Global Market Intelligence
Zydus Lifesciences Stock's Interest Amongst Investors
Investment in Zydus Lifesciences Ltd Shares on INDmoney has dropped by -23.30% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Zydus Lifesciences Ltd Stock has increased by 22% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:22% versus previous 30 day period
Zydus Lifesciences Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Zydus Lifesciences Ltd Annual Profit & Loss
Figures in Rupees Crores
Zydus Lifesciences Ltd Cash Flow
Figures in Rupees Crores
Zydus Lifesciences Stock Shareholding Pattern
Numbers in percentages
Mutual Funds that own Zydus Lifesciences Stock
Check out the Mutual Funds with significant holdings in Zydus Lifesciences.
Funds | Holdings | Shares Held | |
|---|---|---|---|
 Parag Parikh Flexi Cap Direct Growth | 1.26% | 14786344 | |
 Kotak Flexicap Fund Direct Growth | 1.92% | 10500000 | |
 ICICI Prudential Large Cap Fund Direct Plan Growth | 0.58% | 4277967 | |
ICICI Prudential India Opportunities Fund Direct Growth | 0.75% | 2280577 | |
 Nippon India Pharma Fund - Direct Plan - Growth Plan | 2.35% | 2000632 |
Zydus Lifesciences Earnings and Dividends
View detailed summary of the earnings and dividend history of Zydus Lifesciences.
Zydus Lifesciences Ltd Earnings Results
Zydus Lifesciences Ltd’s net profit jumped 3.3% since last year same period to ₹1,466.80Cr in the Q1 2025-2026. On a quarterly growth basis, Zydus Lifesciences Ltd has generated 25.27% jump in its net profits since last 3-months.
Read More about Earnings ResultsZydus Lifesciences Ltd Dividends May,2025
In the quarter ending March 2025, Zydus Lifesciences Ltd has declared dividend of ₹11.00 per share on 19 May 2025 - translating a dividend yield of 1.05%.
Read More about Dividends
Indices Featuring Zydus Lifesciences Stock
Check stock indices that include Zydus Lifesciences.
Insights on Zydus Lifesciences Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 4 quarters, 5.30K Cr → 6.72K Cr (in ₹), with an average increase of 7.2% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 4 quarters, 911.2 Cr → 1.46K Cr (in ₹), with an average increase of 14.6% per quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 6.68% to 6.74% in Jun 2025 quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, ZYDUSLIFE stock has moved up by 3.5%
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, ZYDUSLIFE has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 10.0% return, outperforming this stock by 16.4%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 74.99% of holdings in Jun 2025 quarter
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 6.36% to 5.56% in Jun 2025 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 7.32% to 7.13% in Jun 2025 quarter
About Zydus Lifesciences Ltd
The company has a strong presence in the global market and is known for its high-quality pharmaceutical products. It manufactures a wide range of generic and specialty drugs, including cardiovascular, anti-infective, anti-diabetic, and oncology medicines. Zydus also produces over-the-counter products and nutritional supplements. Some of its top products include Zetia, Atorvastatin, and Metformin.
Zydus Lifesciences Ltd is also known for its popular brands, such as Cadila, Nutralite, and Zydus Wellness. The company has a strong presence in the Indian market, with its products being sold in more than 20,000 stores across the country. It also exports its products to over 100 countries worldwide.
Revenue: ₹6,467.00Cr as on June 2025 (Q1 FY26)
Net Profit: ₹1,486.60Cr as on June 2025 (Q1 FY26)
Listing date: 18 Apr, 2000
Chairperson Name: Pankaj R Patel
| Organisation | Zydus Lifesciences Ltd |
| Headquarters | Ahmedabad |
| Industry | Pharmaceuticals |
| CEO | Pankaj R Patel |
| E-voting on shares | Click here to vote |
FAQs
What is Zydus Lifesciences share price today?
Zydus Lifesciences share price today stands at ₹1036.9 as on at the close of the market. Zydus Lifesciences share today touched a day high of ₹1047 and a low of ₹1033.05.
What is the 52 week high and 52 week low range for Zydus Lifesciences share?
Zydus Lifesciences touched a 52 week high of ₹1135.1 and a 52 week low of ₹795. Zydus Lifesciences share price today i.e. is closed at ₹1036.9, which is -8.65% down from its 52 week high and 30.43% up from its 52 week low.
What is Zydus Lifesciences's market capitalisation today?
Zydus Lifesciences market capitalisation is ₹1,05,126.30 Cr as on .
How to buy Zydus Lifesciences shares?
To buy Zydus Lifesciences shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for ZYDUSLIFE or Zydus Lifesciences Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Zydus Lifesciences shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Zydus Lifesciences trading volume today?
Zydus Lifesciences trading volume is 3.92L as on . This means that 3.92L shares of Zydus Lifesciences were bought and sold on the stock market during today's trading session.